What is the translation of " MEDSEBOJNIH DELOVANJ " in English?

• interaction
• interactions

Examples of using Medsebojnih delovanj in Slovenian and their translations into English

Druge vrste medsebojnih delovanj.
Other types of interaction.

Medsebojnih delovanj ni pričakovati.
No interaction is expected for.

Preglednica 2 prikazuje seznam ocenjenih ali možnih medsebojnih delovanj z zdravili.
Table 2 provides a listing of assessed or potential medicinal product interactions.

Medsebojnih delovanj niso preučevali.
No interaction study has been performed.

Klinični pomen in mehanizmi teh opisanih medsebojnih delovanj niso vedno znani.
The clinical importance and the mechanisms behind these reported interactions are not always known.

Medsebojnih delovanj niso preučevali. Glede.
No interaction study has been performed. Based.

Glede na velikost teh sprememb ni pričakovati klinično pomembnih medsebojnih delovanj, če je umeklidinijev bromid uporabljen sočasno z zaviralci P-gp.
Based on the magnitude of these changes, no clinically relevant interaction is expected when umeclidinium bromide is co-administered with P-gp inhibitors.

Profil medsebojnih delovanj gemfibrozila je zapleten.
The interaction profile of gemfibrozil is complex.

Dronedaron pri človeku šibko zavira CYP 2D6, zato ima predvidoma malo medsebojnih delovanj z antidepresivnimi zdravili, ki se presnovijo s CYP 2D6.
Since dronedarone is a weak inhibitor of CYP 2D6 in humans, it is predicted to have limited interaction on antidepressant medicinal products metabolised by CYP 2D6.

Študije medsebojnih delovanj so pokazale, da pioglitazon nima pomembnegazaučinka na.
Interaction studies have shown that pioglitazone has no relevant effect on either the pharmacokinetics.

Nadalje, rezultati iz študij medsebojnega delovanja s sakvinavir mehkimi kapsulami ne utegnejo napovedovati obsega medsebojnih delovanj z zdravilom Invirase/ ritonavir.
Furthermore, results seen with saquinavir soft capsules may not predict the magnitude of these interactions with Invirase/ ritonavir.

Ni pričakovati nobenih medsebojnih delovanj med pravastatinom in zdravilom INTELENCE.
No interaction between pravastatin and INTELENCE is expected.

Populacijska farmakokinetična analiza in primerjave med študijami niso odkrile farmakokinetičnih medsebojnih delovanj med afliberceptom in zdravili v shemi FOLFIRI.
Population pharmacokinetics analysis and inter study comparisons did not reveal any pharmacokinetic drug-drug interaction between aflibercept and the FOLFIRI regimen.

Klinično pomembnih medsebojnih delovanj s substrati CYP2C9 ni pričakovati.
Clinically significant interactions with CYP2C9 substrates or inhibitors are not anticipated.

Ni še ugotovljeno, kateri encim je odgovoren za presnovo desloratadina, zato ni mogoče povsem izključiti nekaterih medsebojnih delovanj z drugimi zdravili.
The enzyme responsible for the metabolism of desloratadine has not been identified yet, and therefore, some interactions with other medicinal products cannot be fully excluded.

Znakov medsebojnih delovanj z omenjenimi zdravili pri njihovi sočasni uporabi niso našli.
There were no indications of an interaction with these concomitantly administered medicinal products.

Glede na velikost teh sprememb ni pričakovati klinično pomembnih medsebojnih delovanj zdravil, če je kombinacija umeklidinij/vilanterol uporabljena sočasno z zaviralci P-gp.
Based on the magnitude of these changes, no clinically relevant drug interaction is expected when umeclidinium/vilanterol is co-administered with P-gp inhibitors.

Medsebojnih delovanj niso preučevali, vendar jih glede na to, da se ribavirin izloča preko ledvic, ni pričakovati.
Not studied, but no interaction expected based on the renal elimination pathway of ribavirin.

Študije sočasne uporabe esomeprazola z naproksenom ali rofekoksibom med kratkotrajnimi študijami niso pokazale klinično pomembnih farmakokinetičnih medsebojnih delovanj.
Studies evaluating concomitant administration of esomeprazole and either naproxen or rofecoxib did not identify any clinically relevant pharmacokinetic interactions during short-term studies.

Za vodila glede možnih medsebojnih delovanj z drugimi zdravili in priporočila za odmerjanje glejte preglednico 2.
See Table 2 for guidance regarding potential interactions with other medicinal products and dosing recommendations.

Glede na študije medsebojnega delovanja, pri katerih je bil uporabljan samo odmerek 10 mg tadalafila, klinično pomembnih medsebojnih delovanj pri večjih odmerkih ni mogoče popolnoma izključiti.
With regard to those interaction studies where only the 10 mg tadalafil dose was used, clinically relevant interactions at higher doses cannot be completely ruled out.

Preskušanje medsebojnih delovanj je pokazalo primerljivo sistemsko izpostavljenost rifabutinu pri zdravljenju samo s 300 mg rifabutina q. d.
The interaction trial showed a comparable daily systemic exposure for rifabutin between treatment at 300 mg q. d.

Možnih medsebojnih delovanj z drugimi hematopoetskimi rastnimi faktorji in citokini v kliničnih preskušanjih še niso raziskovali.
Possible interactions with other haematopoietic growth factors and cytokines have yet to be investigated in clinical trials.

Možnih medsebojnih delovanj z drugimi hematopoetskimi rastnimi faktorji in citokini v kliničnih preskušanjih še niso raziskovali.
Possible interactions with other haematopoietic growth factors and cytokines have not yet been investigated in clinical trials.

Možnih medsebojnih delovanj z drugimi hematopoetskimi rastnimi faktorji in citokini v kliničnih preskušanjih še niso raziskovali.
Possible interactions with other haematopoietic growth factors and cytokines have not been specifically investigated in clinical trials.

Zato ni pričakovati medsebojnih delovanj ceftarolina z zdravili, ki so substrati ali zaviralci(npr. probenecid) teh prenašalcev.
Therefore, interactions of ceftaroline with medicinal products that are substrates or inhibitors(e.g. probenecid) of these transporters would not be expected.

Profil medsebojnih delovanj gemfibrozila je zapleten in povzroči povečano izpostavljenost mnogih zdravil, če jih dajemo sočasno z gemfibrozilom.
The interaction profile of gemfibrozil is complex resulting in increased exposure of many medicinal products if administered concomitantly with gemfibrozil.

V študijah medsebojnih delovanj zdravila Zurampic in substratov CYP3A pri zdravih osebah je lesinurad zmanjšal koncentracijo sildenafila in amlodipina v plazmi.
In interaction studies conducted in healthy subjects with Zurampic and CYP3A substrates, lesinurad reduced the plasma concentrations of sildenafil and amlodipine.

Medsebojnih delovanj med dronedaronom in losartanom niso opazili in medsebojnih delovanj med dronedaronom in drugimi antagonisti receptorjev angiotenzina II ni pričakovati.
No interaction was observed between dronedarone and losartan and an interaction between dronedarone and other AIIRAs is not expected.